Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

Autor: Matthew N. Mills, Afrin Naz, Chetna Thawani, Chelsea Walker, Nicholas B. Figura, Sergiy Kushchayev, Daniel E. Oliver, Arnold B. Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James K. C. Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed

Publikováno v: BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)

Abstract Background Little is known about the safety and efficacy of concurrent capecitabine and stereotactic radiotherapy in the setting of breast cancer brain metastases (BCBM). Methods Twenty-three patients with BCBM underwent 31 stereotactic sess

Externí odkaz: https://doaj.org/article/433dd3e76f2d4b08babfea9bf2da801c

Revisiting the Concept of Recurrence of Primary Central Nervous System Lymphomas After Complete Response to Methotrexate-Based Therapy: Periventricular Reseeding as the Predominant Mechanism of Recurrence

Autor: Tugce Kutuk, MD, G. Daniel Grass, MD, PhD, Daniel Oliver, MD, Sepideh Mokhtari, MD, Solmaz Sahebjam, MD, Sungjune Kim, MD, PhD, Jose Penagaricano, MD, Hsiang-Hsuan Michael Yu, MD, ScM, Nam Tran, MD, PhD, Arnold Etame, MD, PhD, Jennifer L. Peterson, MD, Peter Forsyth, MD, Timothy Robinson, MD, PhD

Publikováno v: Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100940- (2022)

Purpose: Understanding patterns of relapse for primary central nervous system lymphoma (PCNSL) may inform mechanisms of recurrence and optimal consolidation strategies. In this study, we report patterns of relapse among patients with PCNSL who achiev

Externí odkaz: https://doaj.org/article/9131334063544b268a997fc533f65a16

Contributors

Autor: Sara R. Alcorn, Elizabeth A. Barnes, Mollie A. Biewald, Julie R. Bloom, Toby Bressler, Hannah Lee Brown, Lindsey Buckingham, Anish A. Butala, Whitney Butler, Ronald C. Chen, Edward Chow, Kristopher Dennis, Bernadine Donahue, Lindsay Alexandra Dow, Kevin A. D’Rummo, Christen R. Elledge, Hiral Fontanilla, Gary M. Freedman, Terry Gardiner, Zahra Ghiassi-Nejad, Amardeep Grewal, James Han, Cory Heal, Lauren Hertan, Christine Hill-Kayser, Alexandra Hotca-Cho, Zain Husain, Christopher Allen Jones, Randa Kamel, Do Young Kim, Anthony Koroulakis, Elizabeth Lindenberger, Spencer Chung-Tang Liu, Deborah Marin, Deborah C. Marshall, Emily Jean Martin, Kate Martin, Sarah McAvoy, Kathryn McGrath, Matthew N. Mills, Pranshu Mohindra, R. Sean Morrison, Adam Mutsaers, Timothy K. Nguyen, Anita O’Donovan, Daniel E. Oliver, Ima Paydar, John Plastaras, Beth Popp, Shayna E. Rich, Anupam Rishi, Jared R. Robbins, Kenneth E. Rosenzweig, Michael Rozak, Arjun Sahgal, Robert M. Samstein, Patricia Mae G. Santos, Stephanie Schmitz, Sonam Sharma, Xinglei Shen, Charles B. Simone, Kunal K. Sindhu, Vinita Singh, Alexander Spektor, Neil K. Taunk, Karen Terry, May N. Tsao, Yolanda D. Tseng, Tanya J. Uritsky, Vincent Vanston, Veena Venkatachalam, Jennifer Vogel, Graeme Williams, Robert J. Wilson, Christopher M. Wright, Divya Yerramilli, Sun K. Yi, Hsiang-Hsuan Michael Yu, Ali John Zarrabi, Batya Reckson

Publikováno v: Palliative Radiation Oncology ISBN: 9780323876889

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::000b3d0f37de7aa2c2ffb03ca09c018c
https://doi.org/10.1016/b978-0-323-87688-9.00004-0

Clinical outcomes of non–small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone

Autor: Ammoren E. Dohm, Joseph D. Tang, Matthew N. Mills, Casey L. Liveringhouse, Maria L. Sandoval, Bradford A. Perez, Timothy J. Robinson, Benjamin C. Creelan, Jhanelle E. Gray, Arnold B. Etame, Michael A. Vogelbaum, Peter Forsyth, Hsiang-Hsuan Michael Yu, Daniel E. Oliver, Kamran A. Ahmed

Publikováno v: Journal of Neurosurgery. :1-8

OBJECTIVE Immune checkpoint inhibitors (ICIs) and epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) are commonly used in the systemic management of non–small cell lung cancer (NSCLC) brain metastases (BMs). However, optimizi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2244bfd0522b658f256e17c53fc8ebfd
https://doi.org/10.3171/2022.9.jns221896

Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-β1 (TGF-β1).

Autor: Jung-Pan Wang, Hsiang-Hsuan Michael Yu, En-Rung Chiang, Jir-You Wang, Po-Hsin Chou, Shih-Chieh Hung

Publikováno v: PLoS ONE, Vol 13, Iss 6, p e0198326 (2018)

Treatment for musculoskeletal fibromatosis remains challenging. Surgical excision for fibromatosis is the standard therapy but recurrence remains high. Corticosteroids, an anti-fibrogenic compound, have been used to treat early stage palmar fibromato

Externí odkaz: https://doaj.org/article/6dde985a13114f2db00817c746bd7d0f